文献速递肿瘤 PET/CT

来氟米特使用对一例神经内分泌肿瘤患者68Ga-DOTATATE生物分布的影响

Effect of Leflunomide Use on 68Ga-DOTATATE Biodistribution in a Case With Neuroendocrine Tumor.
PubMed 文献 · Clin Nucl Med · 2023-01-01

一例58岁男性胰腺来源高分化神经内分泌肿瘤术后患者,在疾病缓解期因类风湿关节炎接受来氟米特治疗6个月,复查68Ga-DOTATATE PET/CT除疾病缓解外,还观察到部分组织和器官DOTATATE摄取改变。本文报道来氟米特使用后68Ga-DOTATATE PET/CT表现的变化。

要点

  • 胰腺来源高分化神经内分泌肿瘤术后随访行68Ga-DOTATATE PET/CT示疾病缓解。
  • 因类风湿关节炎接受来氟米特治疗6个月后复查68Ga-DOTATATE PET/CT。
  • 复查除疾病缓解外,部分组织和器官DOTATATE摄取出现改变。

核心结论

  • 来氟米特使用后68Ga-DOTATATE PET/CT复查显示疾病缓解,同时部分组织和器官DOTATATE摄取出现改变。

研究设计与样本

  • 本文为病例报告,报道一例58岁男性胰腺来源高分化神经内分泌肿瘤术后患者。
  • 患者在疾病缓解后因类风湿关节炎接受来氟米特治疗6个月,随后复查68Ga-DOTATATE PET/CT。

主要发现

  • 首次68Ga-DOTATATE PET/CT表现与疾病缓解一致。
  • 来氟米特治疗6个月后复查68Ga-DOTATATE PET/CT,除疾病缓解外,部分组织和器官DOTATATE摄取出现改变。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A 58-year-old man who underwent surgery for a well-differentiated neuroendocrine tumor of pancreatic origin was evaluated with 68Ga-DOTATATE PET/CT imaging in the follow-up period. After PET/CT findings consistent with disease remission, the patient was started on leflunomide treatment with the diagnosis of rheumatoid arthritis. The patient received leflunomide for 6 months. Then, 68Ga-DOTATATE PET/CT scan was repeated to evaluate the primary disease outcome. Besides the disease remission, we also observed alterations in DOTATATE uptakes of some tissues and organs. In this case, we present the changes in 68Ga-DOTATATE PET/CT scan findings after leflunomide use.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Tatar G, Beyhan E, Arslan E, et al. Effect of Leflunomide Use on 68Ga-DOTATATE Biodistribution in a Case With Neuroendocrine Tumor. Clin Nucl Med. 2023. PMID: 36607376. doi:10.1097/RLU.0000000000004517

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。